Intelligent Bio Solutions (INBS) Equity Average (2020 - 2024)
Intelligent Bio Solutions has reported Equity Average over the past 5 years, most recently at $7.1 million for Q1 2024.
- Quarterly results put Equity Average at $7.1 million for Q1 2024, down 12.59% from a year ago — trailing twelve months through Mar 2024 was $7.1 million (down 12.59% YoY), and the annual figure for FY2023 was $5.1 million, down 52.52%.
- Equity Average for Q1 2024 was $7.1 million at Intelligent Bio Solutions, up from $2.2 million in the prior quarter.
- Over the last five years, Equity Average for INBS hit a ceiling of $17.3 million in Q1 2021 and a floor of -$5.9 million in Q1 2020.
- Median Equity Average over the past 5 years was $7.6 million (2022), compared with a mean of $6.3 million.
- Biggest five-year swings in Equity Average: surged 445.03% in 2021 and later tumbled 71.6% in 2023.
- Intelligent Bio Solutions' Equity Average stood at $7.9 million in 2020, then skyrocketed by 49.65% to $11.8 million in 2021, then tumbled by 34.35% to $7.7 million in 2022, then tumbled by 71.6% to $2.2 million in 2023, then surged by 222.31% to $7.1 million in 2024.
- The last three reported values for Equity Average were $7.1 million (Q1 2024), $2.2 million (Q4 2023), and $2.5 million (Q3 2023) per Business Quant data.